Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors-Reference-Cited by-同舟云学术

Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors

Published:2020-11-23 Issue:4 Volume:16 Page:640-645
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Wagner Stefan¹^ORCID,Moura Gatti Fernando²³^ORCID,Silva Daniel G.⁴^ORCID,Ortiz Zacarias Natalia V.⁵,Zweemer Annelien J. M.⁵,Hermann Sven⁴^ORCID,De Maria Monica⁶,Koch Michael⁷^ORCID,Weiss Christina⁷^ORCID,Schepmann Dirk²,Heitman Laura H.⁵,Tschammer Nuska⁸^ORCID,Kopka Klaus⁹¹⁰^ORCID,Junker Anna²⁴^ORCID

Affiliation:

1. Department of Nuclear Medicine University Hospital Münster Albert-Schweitzer-Campus 1, Building A1 48149 Münster Germany

2. Institut für Pharmazeutische und Medizinische Chemie der Universität Münster Corrensstraße 48 48149 Münster Germany

3. Faculdade de Ciências Farmacêuticas Universidade de São Paulo Av. Prof. Lineu Prestes, 580 CEP 05508-900 São Paulo SP Brazil

4. European Institute for Molecular Imaging (EIMI) Waldeyerstraße 15 48149 Münster Germany

5. Leiden Academic Centre for Drug Research (LACDR) Leiden University Einsteinweg 55 2333 CC Leiden (The Netherlands

6. Department of Developmental Biology Friedrich Alexander University Staudtstraße 5 91058 Erlangen Germany

7. Bayer AG Research & Development Lead Discovery, Wuppertal Aprather Weg 18a, Gebäude 456 42096 Wuppertal Germany

8. Department of Chemistry and Pharmacy Emil Fischer Center Friedrich Alexander University Erlangen–Nürnberg Schuhstraße 19 91052 Erlangen Germany

9. Helmholtz-Zentrum Dresden-Rossendorf Institut für Radiopharmazeutische Krebsforschung Bautzner Landstraße 400 01328 Dresden Germany

10. Faculty of Chemistry and Food Chemistry Technische Universität Dresden 01062 Dresden Germany

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202000728

Reference20 articles.

2. Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury

3. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases

4. The CCR2 receptor as a therapeutic target

5. PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokine receptor PET imaging: Bridging molecular insights with clinical applications;Nuclear Medicine and Biology;2024-07

2. Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET;Nuclear Medicine and Biology;2024-03

3. Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica;Frontiers in Medicine;2022-06-06

4. Potential PET tracers for imaging of tumor-associated macrophages;EJNMMI Radiopharmacy and Chemistry;2022-05-08

5. The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease;Journal of Nuclear Medicine;2021-04-16